Navigation Links
Halt Uterine Fibroid Study Attracts National Media Attention
Date:2/1/2010

LIVERMORE, Calif., Feb. 1 /PRNewswire/ -- The Wall Street Journal, CBS, and other popular news outlets have recently featured headline stories about a clinical study that is recruiting patients suffering with uterine fibroids.  "We're not at all surprised by the attention this study is getting from the media," said Russ DeLonzor, President and Chief Operating Officer of Halt Medical, Inc., a medical technology company headquartered near San Francisco.  Fibroids are benign tumors of the uterus that cause serious, debilitating symptoms including heavy menstrual bleeding, severe cramping, urinary problems, and painful intercourse. Currently the only cure that the gynecologist can offer to patients with fibroids involves major surgery.  "Each year nearly 250,000 women in the US undergo radical surgery to remove their entire uterus rather than to continue suffering with their fibroid symptoms," according to Mr. DeLonzor.  About 8 million women have fibroids, or leiomyomas of the uterus.  "So many lives are impacted in some way by fibroids.  It's no surprise that a clinical study of an outpatient procedure which targets the fibroids while sparing the uterus would gain such widespread attention from the media."   Details of who may qualify for the Halt Uterine Fibroid Study and participating clinical sites are available through the National Institutes of Health at:  clinicaltrials.gov/ct2/show/NCT00874029

SOURCE Halt Medical, Inc.


'/>"/>
SOURCE Halt Medical, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1

Related medicine news :

1. Gorilla Receives State-Of-The-Art Treatment for Uterine Fibroids from Interventional Radiologists
2. Society of Gynecologic Oncologists Provides Guidelines for Offering Genetic Risk Assessment to Women With a Personal or Family History of Breast, Ovarian, Uterine or Colorectal Cancer
3. Few Women Hear About Uterine Fibroid Embolization Treatment Option Directly From Gynecologists
4. UFE Highly Effective in Cases Where Focused Ultrasound to Treat Uterine Fibroids Failed
5. Major surgery no longer needed for the removal of uterine fibroids
6. Scientists ID Uterine Muscle Switch for Contractions
7. Black women with uterine cancers more likely to die than white patients
8. Gene Variant Raises Risk of Uterine Fibroids
9. Prominent Chicago Gynecologists Launch Treatment Project To Raise Awareness Among African American Women of Non-Invasive Ultrasound Uterine Fibroid Procedure
10. Singapore Premier Women's Hospital Offers Contactless Surgery for Uterine Fibroids
11. Chamberlain Group Announces New Uterine Robotic Surgery Training Device
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/13/2017)... ... ... As health professionals work to improve their approach to healthcare, there is ... than filling out a survey; in many cases health professionals and patients are working ... and research on the importance of active engagement with patients and members of the ...
(Date:10/13/2017)... (PRWEB) , ... October 13, 2017 , ... The American ... to become its next President and Chief Executive Officer, succeeding Dr. James C. Puffer ... Elect beginning July 1, 2018 until Dr. Puffer’s retirement at the end of 2018. ...
(Date:10/13/2017)... ... October 13, 2017 , ... PurhealthRX , a leading Health and Nutrition ... the Purzorb™process to full spectrum CBD oil will revolutionize the rapidly growing CBD market ... can be easily incorporated into liquid products, while reducing costs to end users. , ...
(Date:10/13/2017)... ... ... Lori R. Somekh, founder of the Law Office of Somekh & Associates ... special needs planning attorneys. “Membership in ElderCounsel helps our office remain up to date ... elder law attorneys nationwide,” said Somekh. , ElderCounsel was founded by ...
(Date:10/13/2017)... Calif. (PRWEB) , ... October 13, 2017 , ... Many ... dementia. However, many long-term care insurance companies have a waiver for care if the ... 90-day elimination period, when the family pays for care, is often waived, so the ...
Breaking Medicine News(10 mins):
(Date:9/18/2017)... 18, 2017 EpiVax, Inc. ("EpiVax") ... and immune engineering, today announced a new ... (H7N9) vaccine. ... influenza and presents a challenge for traditional ... to be effective. Using state-of-the-art bioinformatics and molecular ...
(Date:9/12/2017)... NEW YORK , Sept. 12, 2017   EcoVadis , ... supply chains, has published the first annual edition of its Global CSR ... than 20,400 companies evaluated by EcoVadis, based on Scorecard Ratings that analyzed ... ... & Performance Index ...
(Date:9/12/2017)... , Sept. 12, 2017  ValGenesis Inc., the ... (VLMS), is pleased to announce the appointment of ... of its Board of Directors and Chairman of ... enables life science companies to manage their entire ... of paper in this process. Furthermore, ValGenesis VLMS ...
Breaking Medicine Technology: